Skip to content
10-K

Annual Report

agilon health, inc. AGL

0001628280-26-011655

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 414.87M sh
Shares Diluted FY 2025 · Dec 31, 2025 413.97M sh
Shares Diluted FY 2025 · Dec 31, 2024 410.97M sh
Shares Diluted FY 2025 · Dec 31, 2023 408.92M sh
Capex FY 2025 · Dec 31, 2025 $13.24M
Capex FY 2025 · Dec 31, 2024 $13.25M
Capex FY 2025 · Dec 31, 2023 $15.83M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$105.76M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$57.78M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$156.2M
Long Term Debt FY 2025 · Dec 31, 2025 $15.75M
Long Term Debt FY 2025 · Dec 31, 2024 $34.9M
Short Term Debt FY 2025 · Dec 31, 2025 $19.24M
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $173.71M
Cash And Equivalents FY 2025 · Dec 31, 2024 $188.23M
Current Liabilities FY 2025 · Dec 31, 2025 $1.08B
Current Liabilities FY 2025 · Dec 31, 2024 $1.15B
Total Liabilities FY 2025 · Dec 31, 2025 $1.14B
Total Liabilities FY 2025 · Dec 31, 2024 $1.26B
Current Assets FY 2025 · Dec 31, 2025 $1.1B
Current Assets FY 2025 · Dec 31, 2024 $1.46B
Total Assets FY 2025 · Dec 31, 2025 $1.27B
Total Assets FY 2025 · Dec 31, 2024 $1.73B
Sga Expense FY 2025 · Dec 31, 2025 $238.54M
Sga Expense FY 2025 · Dec 31, 2024 $268.91M
Sga Expense FY 2025 · Dec 31, 2023 $285.76M
Net Income FY 2025 · Dec 31, 2025 −$391.35M
Net Income FY 2025 · Dec 31, 2024 −$260.15M
Net Income FY 2025 · Dec 31, 2023 −$262.6M
Operating Income FY 2025 · Dec 31, 2025 −$463.24M
Operating Income FY 2025 · Dec 31, 2024 −$292.13M
Operating Income FY 2025 · Dec 31, 2023 −$232.13M
Revenue FY 2025 · Dec 31, 2025 $5.93B
Revenue FY 2025 · Dec 31, 2024 $6.06B
Revenue FY 2025 · Dec 31, 2023 $4.32B
Stock Repurchased FY 2025 · Dec 31, 2023 $200M